« Back

ALK-Abelló, ALK-Abelló starts up clinical development program with ragweed tablet in USA

May 23, 2006

PDF Version

Supporting Materials:
ALK-Abelló starts up Phase I study in the USA with a tablet-based vaccine
against ragweed allergy